4//SEC Filing
Hamm Robert A 4
Accession 0001127602-09-014429
CIK 0000875045other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 11:26 AM ET
Size
7.1 KB
Accession
0001127602-09-014429
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Hamm Robert A
EVP, Pharma. Oper. & Tech.
Transactions
- Sale
Common Stock
2009-06-22$49.75/sh−2,194$109,143→ 38,526.41 total - Sale
Common Stock
2009-06-22$50.77/sh−1,000$50,768→ 37,526.41 total
Footnotes (4)
- [F1]Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]This represents the weighted average price for shares sold at a range between $49.38 (low) and $50.21 (high).
- [F3]Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- [F4]This represents the weighted average price for shares sold at a range between $50.49 (low) and $50.94 (high).
Documents
Issuer
BIOGEN IDEC INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001335018
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 11:26 AM ET
- Size
- 7.1 KB